Zydus Cadila gets final approval for Sirolimus tablets with marketing exclusivity pharmabiz.com Zydus Cadila has received the final US FDA approval to market Sirolimus tablets 0.5 mg with 180 days of marketing exclusivity. As per IMS data in 2013, the sales of Sirolimus 0.5 mg was estimated at US$ 11.7 million and the total market was ... |
